- Company Overview for NUCLEOME THERAPEUTICS LIMITED (12109297)
- Filing history for NUCLEOME THERAPEUTICS LIMITED (12109297)
- People for NUCLEOME THERAPEUTICS LIMITED (12109297)
- More for NUCLEOME THERAPEUTICS LIMITED (12109297)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
22 Oct 2024 | RP04SH01 |
Second filing of a statement of capital following an allotment of shares on 4 October 2024
|
|
04 Oct 2024 | SH01 |
Statement of capital following an allotment of shares on 27 August 2024
|
|
16 Aug 2024 | CS01 | Confirmation statement made on 16 August 2024 with updates | |
09 Aug 2024 | SH08 | Change of share class name or designation | |
01 Aug 2024 | TM02 | Termination of appointment of Phil Boyd as a secretary on 26 July 2024 | |
30 Jul 2024 | AP01 | Appointment of Mark Bodmer as a director on 24 July 2024 | |
30 Jul 2024 | SH01 |
Statement of capital following an allotment of shares on 15 July 2024
|
|
25 Jun 2024 | CH01 | Director's details changed for John Davis on 25 June 2024 | |
31 May 2024 | CH01 | Director's details changed for Dr Bauke Anninga on 21 October 2022 | |
31 May 2024 | CH03 | Secretary's details changed for Phil Boyd on 21 October 2022 | |
28 May 2024 | SH01 |
Statement of capital following an allotment of shares on 22 May 2024
|
|
16 May 2024 | AP01 | Appointment of John Davis as a director on 15 February 2024 | |
16 May 2024 | TM01 | Termination of appointment of Danuta Mariola Jeziorska as a director on 19 April 2024 | |
20 Feb 2024 | PSC05 | Change of details for Oxford Science Enterprises Plc as a person with significant control on 26 August 2023 | |
15 Feb 2024 | SH01 |
Statement of capital following an allotment of shares on 14 February 2024
|
|
04 Jan 2024 | AA | Accounts for a small company made up to 31 July 2023 | |
13 Dec 2023 | SH01 |
Statement of capital following an allotment of shares on 13 December 2023
|
|
08 Nov 2023 | SH01 |
Statement of capital following an allotment of shares on 8 September 2023
|
|
08 Nov 2023 | SH01 |
Statement of capital following an allotment of shares on 26 August 2023
|
|
07 Sep 2023 | AP01 | Appointment of Dr Russell George Greig as a director on 6 September 2023 | |
07 Aug 2023 | CS01 | Confirmation statement made on 7 August 2023 with updates | |
02 Mar 2023 | AP01 | Appointment of Miss Emma Johnson as a director on 2 March 2023 | |
14 Dec 2022 | AA | Accounts for a small company made up to 31 July 2022 | |
14 Dec 2022 | RP04SH01 |
Second filing of a statement of capital following an allotment of shares on 10 November 2022
|
|
25 Nov 2022 | RP04PSC05 | Second filing to change the details of Oxford Science Enterprises Plc as a person with significant control |